Millennium Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Millennium Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-220	Closed	-$33.7K	–	6605
2024 Q1	$33.7K	Sell	220 -125	-36%	-$13.5K	﹤0.01%	5750
2023 Q4	$40.2K	Buy	+345	New	+$53.8K	﹤0.01%	5518
2023 Q2	–	Sell	-546	Closed	-$84K	–	6741
2023 Q1	$84K	Buy	546 +4	+0.7%	+$718	﹤0.01%	5477
2022 Q4	$73K	Buy	542 +321	+145%	+$64.1K	﹤0.01%	5678
2022 Q3	$44K	Buy	221 +38	+21%	+$12.2K	﹤0.01%	6230
2022 Q2	$64K	Sell	183 -210	-53%	-$88.1K	﹤0.01%	6097
2022 Q1	$230K	Sell	393 -86	-18%	-$51.1K	﹤0.01%	5751
2021 Q4	$440K	Sell	479 -1	-0.2%	-$1.07K	﹤0.01%	5172
2021 Q3	$601K	Sell	480 -275	-36%	-$533K	﹤0.01%	5185
2021 Q2	$2.38M	Buy	755 +726	+2,503%	+$2.87M	﹤0.01%	3754
2021 Q1	$178K	Buy	+29	New	+$210K	﹤0.01%	5529
2020 Q4	–	Sell	-12	Closed	-$70	–	5629
2020 Q3	$70	Sell	12 -369	-97%	-$2.15M	﹤0.01%	4271
2020 Q2	$2.38M	Buy	+381	New	+$2.58M	﹤0.01%	2398
2018 Q3	–	Sell	-59	Closed	-$1.74M	–	4311
2018 Q2	$1.74M	Buy	+59	New	+$2.29M	﹤0.01%	2494

Other funds holding YARW

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Millennium Management's YARW Position: Q2 2024 in Review

Millennium Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2024, closing a stake of 220 shares — an estimated $33.7K sold.

Millennium Management first reported a position in YARW in Q2 2018 and held it in 14 quarters. The position peaked at $2.38M in Q2 2021. 31 funds tracked by Wall St. Rank hold YARW as of Q2 2024.

Millennium Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Millennium Management sold 220 Yarrow Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $33.7K.
Millennium Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
Millennium Management's Yarrow Bioscience, Inc. Common Stock position peaked at $2.38M in Q2 2021.
31 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.